Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: Alzheimer's disease,preclinical (Click to remove) Practice Guide Update Summary: Mild Cognitive Impairment Neurol 90:126-135, Petersen, R.C.,et al, 2018 Changing Concepts of Alzheimer Disease JAMA 35:2458-2459, McKhann, G.M., 2011 CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment JAMA 302:385-393,436,452, Mattsson,N.,et al, 2009 Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study Neurol 73:754-760, 744, Okello,A.,et al, 2009 A 10-Item Smell Identification Scale Related to Risk for Alzheimers Disease Ann Neurol 58:155-160, Taberr,M.H.,et al, 2005 Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future Radiology 226:315-336, Petrella,J.R.,et al, 2003 Altered Brain Activation in Cognitively Intact Individuals at High Risk for Alzheimer's Disease Neurol 53:1391-1396, Smith,C.D.,et al, 1999 Preclinical Prediction of Alzheimer's Disease Using SPECT Neurol 50:1563-1571, Johnson,K.A.,et al, 1998 The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective JAMA 277:832-836, Post,S.G.,et al, 1997 Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the e4Allele for Apolipoprotein E NEJM 334:752-758, 7911996., Reiman,E.M.,et al, 1996 Statement of Use of Apolipoprotein E Testing for Alzheimer Disease JAMA 274:1627-1629, Farrer,L.A.,et al, 1995 A Low, "Normal"Score on the Mini-Mental State Exam Predicts Development of Dementia after Three Years JAGS 43:656-661, Braekhus,A.,et al, 1995 Showing articles 0 to 12 of 12